• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.32% Nasdaq Down 0.62%

    Idera Pharmaceuticals, Inc. (IDRA)

    -NasdaqCM
    1.66 Down 0.05(2.92%) Apr 29, 4:00PM EDT
    |After Hours : 1.66 0.00 (0.00%) Apr 29, 4:00PM EDT
    Prev Close:1.71
    Open:1.71
    Bid:1.59 x 5000
    Ask:1.75 x 2600
    1y Target Est:5.00
    Beta:2.59464
    Earnings Date:May 9 - May 13 (Est.)
    Day's Range:1.65 - 1.75
    52wk Range:1.50 - 4.42
    Volume:622,074
    Avg Vol (3m):989,303
    Market Cap:201.32M
    P/E (ttm):N/A
    EPS (ttm):-0.45
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    IDRADown 2.92%201.32M
    PFEDown 0.61%202.54B
    DVAXDown 6.39%631.49M

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):3,317.68
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-16) :-0.45
    Quarterly EPS Est (Mar-16) :-0.11
    Mean Recommendation*:1.8
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Idera Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for oncology and rare diseases in the United States. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback